Ronda Lun
Positions
Clinical Assistant Professor
Cumming School of Medicine, Department of Clinical Neurosciences
Full Member
Hotchkiss Brain Institute
Full Member
O'Brien Institute for Public Health
Member
Arnie Charbonneau Cancer Institute
Contact information
Preferred method of communication
Email: rlun@ucalgary.ca
Background
Biography
Dr. Ronda Lun did her medical school training at the University of Calgary. She completed her Adult Neurology residency at the University of Ottawa, while enrolled in the Clinical Investigator Program, allowing her to obtain a Masters of Science Epidemiology and Biostatistics degree. She obtained an ACGME-accredited fellowship in Vascular Neurology through Stanford University and was awarded the highly competitive CIHR Fellowship award to support her fellowship training. She has published 56 peer-reviewed articles in scientific journals to date, with 26 first author publications. She has been invited to speak at multiple international conferences, including the International Stroke Conference, and the 2025 American Academy of Neurology conference as a plenary session speaker. She has also been the recipient of multiple competitive awards at a national and international level. Her research interests include cancer and stroke, intracerebral hemorrhage, and stroke clinical trials.
Research
Areas of Research
- Improving the diagnosis of occult malignancy in cryptogenic ischemic stroke patients
- Optimizing treatment strategies of ischemic stroke in cancer patients
- Prevention strategies for stroke in cancer patients
My research interest is in stroke in cancer patients. Cancer-associated hypercoagulability is known to cause both venous and arterial thromboembolism, but much of the thrombosis research has been limited to venous thromboembolism. My research program aims to improve our understanding of the relationship between stroke, through the following methods: 1) improve our understanding of optimal screening and diagnostic methods for occult cancer in cryptogenic stroke, 2) using administrative data to characterize outcomes in cancer patients with stroke and to develop clinical prediction tools for stroke in cancer patients and 3) advance our understanding of cancer-associated hypercoagulability using multiple imaging and biomarkers.
Publications
Are you the profile owner?
Login to edit.